We are delighted to announce the following companies as finalists in our BioNewsRound Award 2023. Voting is now open for everyone, please click on the voting button below.

Astex – Astex hails trials success of superdrug that saves lives and cuts recurrence risk for thousands of breast cancer patients

AstraZeneca – AstraZeneca and Quell partner on engineered Treg cell therapies that have the potential to be curative in Type 1 Diabetes and Inflammatory Bowel Diseaseline up $2.85bn alliance

Macomics – Macomics and Ono Pharmaceutical partner to discover and develop macrophage-targeting antibody therapy

PharmEnable – PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases

SiSaf – FDA Grants SiSaf’s Innovative siRNA Therapy SIS-101-ADO Orphan Drug Designation and Rare Pediatric Disease Designation for the Treatment of Autosomal Dominant Osteopetrosis

ValiRx – ValiRx signs IP license agreement with King’s College London to progress triple negative breast cancer treatment 

Uncommon – Meat from animal cells’ pioneer raises $30m to target $427bn market 

The winner will be announced during the afternoon of the ON Helix conference on 6 July 2023.